# Playboy, Inc.: financial statements, quarterly

PLBY · Nasdaq · CIK 1803914 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/plby.md) · [Financials](/companies/plby/financials.md) · [Filings](/companies/plby/filings.md) · [Insiders](/companies/plby/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/plby/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [16.3](/filings/0001803914-24-000103.md) | [91.9 d](/filings/0001803914-25-000030.md) | [28.3](/filings/0001803914-25-000087.md) | [24.9](/filings/0001803914-25-000122.md) | [29.4](/filings/0001628280-25-051637.md) | [33.5 d](/filings/0001628280-26-018238.md) | [28.9](/filings/0001628280-26-033562.md) | [28.1](/filings/0001628280-26-055279.md) | [29.0](/filings/0001628280-25-051637.md) | [34.9 d](/filings/0001628280-26-018238.md) | [30.2](/filings/0001628280-26-033562.md) | [31.2](/filings/0001628280-26-055279.md) |
| Cost of revenue | $m | [1.3](/filings/0001803914-24-000103.md) | [40.6 d](/filings/0001803914-25-000030.md) | [12.5](/filings/0001803914-25-000087.md) | [8.0](/filings/0001803914-25-000122.md) | [11.5](/filings/0001628280-25-051637.md) | [9.8 d](/filings/0001628280-26-018238.md) | [9.1](/filings/0001628280-26-033562.md) | [9.7](/filings/0001628280-26-055279.md) | [7.0](/filings/0001628280-25-051637.md) | [9.3 d](/filings/0001628280-26-018238.md) | [9.5](/filings/0001628280-26-033562.md) | [8.4](/filings/0001628280-26-055279.md) |
| Gross profit | $m | not reported | not reported | [15.8](/filings/0001803914-25-000087.md) | [16.9](/filings/0001803914-25-000122.md) | [18.0](/filings/0001628280-25-051637.md) | [23.7 d](/filings/0001628280-26-018238.md) | [19.8](/filings/0001628280-26-033562.md) | [18.4](/filings/0001628280-26-055279.md) | [22.0](/filings/0001628280-25-051637.md) | [25.6 d](/filings/0001628280-26-018238.md) | [20.7](/filings/0001628280-26-033562.md) | [22.8](/filings/0001628280-26-055279.md) |
| Selling, general and administrative | $m | [15.5](/filings/0001803914-24-000103.md) | [59.0 d](/filings/0001803914-25-000030.md) | [22.0](/filings/0001803914-25-000087.md) | [25.5](/filings/0001803914-25-000122.md) | [24.5](/filings/0001628280-25-051637.md) | [26.9 d](/filings/0001628280-26-018238.md) | [25.4](/filings/0001628280-26-033562.md) | [22.4](/filings/0001628280-26-055279.md) | [20.4](/filings/0001628280-25-051637.md) | [22.8 d](/filings/0001628280-26-018238.md) | [23.2](/filings/0001628280-26-033562.md) | [19.8](/filings/0001628280-26-055279.md) |
| Operating income | $m | [(1.6)](/filings/0001803914-24-000103.md) | [(88.7) d](/filings/0001803914-25-000030.md) | [(8.9)](/filings/0001803914-25-000087.md) | [(9.2)](/filings/0001803914-25-000122.md) | [(28.3)](/filings/0001628280-25-051637.md) | [(4.5) d](/filings/0001628280-26-018238.md) | [(6.3)](/filings/0001628280-26-033562.md) | [(5.9)](/filings/0001628280-26-055279.md) | [1.4](/filings/0001628280-25-051637.md) | [2.7 d](/filings/0001628280-26-018238.md) | [(1.6)](/filings/0001628280-26-033562.md) | [3.0](/filings/0001628280-26-055279.md) |
| Interest expense | $m | [6.6](/filings/0001803914-24-000011.md) | [5.7 d](/filings/0001803914-24-000022.md) | [6.4](/filings/0001803914-24-000035.md) | [6.6](/filings/0001803914-25-000122.md) | [6.7](/filings/0001628280-25-051637.md) | [4.0 d](/filings/0001628280-26-018238.md) | [1.9](/filings/0001628280-26-033562.md) | [1.9](/filings/0001628280-26-055279.md) | [1.9](/filings/0001628280-25-051637.md) | [2.5 d](/filings/0001628280-26-018238.md) | [2.5](/filings/0001628280-26-033562.md) | [2.2](/filings/0001628280-26-055279.md) |
| Income tax | $m | [(0.9)](/filings/0001803914-24-000103.md) | [(6.0) d](/filings/0001803914-25-000030.md) | [1.1](/filings/0001803914-25-000087.md) | [0.6](/filings/0001803914-25-000122.md) | [0.6](/filings/0001628280-25-051637.md) | [0.9 d](/filings/0001628280-26-018238.md) | [1.1](/filings/0001628280-26-033562.md) | [0.9](/filings/0001628280-26-055279.md) | [(0.6)](/filings/0001628280-25-051637.md) | [(2.7) d](/filings/0001628280-26-018238.md) | [0.9](/filings/0001628280-26-033562.md) | [1.1](/filings/0001628280-26-055279.md) |
| Net income | $m | [(7.2)](/filings/0001803914-24-000103.md) | [(3.8) d](/filings/0001803914-25-000030.md) | [(16.4)](/filings/0001803914-25-000087.md) | [(16.7)](/filings/0001803914-25-000122.md) | [(33.8)](/filings/0001628280-25-051637.md) | [(12.5) d](/filings/0001628280-26-018238.md) | [(9.0)](/filings/0001803914-25-000087.md) | [(7.7)](/filings/0001803914-25-000122.md) | [0.5](/filings/0001628280-25-051637.md) | [3.6 d](/filings/0001628280-26-018238.md) | [(4.0)](/filings/0001628280-26-033562.md) | [0.2](/filings/0001628280-26-055279.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0001803914-24-000103.md) | not reported | [(0.23)](/filings/0001803914-25-000087.md) | [(0.23)](/filings/0001803914-25-000122.md) | [(0.45)](/filings/0001628280-25-051637.md) | not reported | [(0.10)](/filings/0001628280-26-033562.md) | [(0.08)](/filings/0001628280-26-055279.md) | [0.00](/filings/0001628280-25-051637.md) | not reported | [(0.03)](/filings/0001628280-26-033562.md) | [0.00](/filings/0001628280-26-055279.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0001803914-24-000103.md) | not reported | [(0.23)](/filings/0001803914-25-000087.md) | [(0.23)](/filings/0001803914-25-000122.md) | [(0.45)](/filings/0001628280-25-051637.md) | not reported | [(0.10)](/filings/0001628280-26-033562.md) | [(0.08)](/filings/0001628280-26-055279.md) | [0.00](/filings/0001628280-25-051637.md) | not reported | [(0.03)](/filings/0001628280-26-033562.md) | [0.00](/filings/0001628280-26-055279.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.0](/filings/0001803914-24-000103.md) | [28.1](/filings/0001803914-25-000030.md) | [19.0](/filings/0001803914-25-000087.md) | [16.9](/filings/0001803914-25-000122.md) | [9.5](/filings/0001628280-25-051637.md) | [30.9](/filings/0001628280-26-018238.md) | [23.7](/filings/0001628280-26-033562.md) | [19.6](/filings/0001628280-26-055279.md) | [27.5](/filings/0001628280-25-051637.md) | [37.8](/filings/0001628280-26-055279.md) | [30.2](/filings/0001628280-26-033562.md) | [31.9](/filings/0001628280-26-055279.md) |
| Current assets | $m | [74.1](/filings/0001803914-24-000011.md) | [69.7](/filings/0001803914-25-000030.md) | [56.7](/filings/0001803914-24-000035.md) | [47.5](/filings/0001803914-24-000071.md) | [90.3](/filings/0001803914-24-000103.md) | [57.5](/filings/0001628280-26-018238.md) | [45.5](/filings/0001803914-25-000087.md) | [39.5](/filings/0001803914-25-000122.md) | [51.3](/filings/0001628280-25-051637.md) | [65.5](/filings/0001628280-26-055279.md) | [59.5](/filings/0001628280-26-033562.md) | [59.3](/filings/0001628280-26-055279.md) |
| Total assets | $m | [360](/filings/0001803914-24-000011.md) | [334](/filings/0001803914-25-000030.md) | [309](/filings/0001803914-24-000035.md) | [302](/filings/0001803914-24-000071.md) | [272](/filings/0001803914-24-000103.md) | [285](/filings/0001628280-26-018238.md) | [271](/filings/0001803914-25-000087.md) | [264](/filings/0001803914-25-000122.md) | [278](/filings/0001628280-25-051637.md) | [292](/filings/0001628280-26-055279.md) | [286](/filings/0001628280-26-033562.md) | [289](/filings/0001628280-26-055279.md) |
| Current liabilities | $m | [72.8](/filings/0001803914-24-000011.md) | [58.9](/filings/0001803914-25-000030.md) | [47.7](/filings/0001803914-24-000035.md) | [52.9](/filings/0001803914-24-000071.md) | [62.7](/filings/0001803914-24-000103.md) | [55.8](/filings/0001628280-26-018238.md) | [54.0](/filings/0001803914-25-000087.md) | [52.4](/filings/0001803914-25-000122.md) | [55.5](/filings/0001628280-25-051637.md) | [63.8](/filings/0001628280-26-055279.md) | [59.7](/filings/0001628280-26-033562.md) | [74.8](/filings/0001628280-26-055279.md) |
| Total liabilities | $m | [312](/filings/0001803914-24-000011.md) | [289](/filings/0001803914-25-000030.md) | [280](/filings/0001803914-24-000035.md) | [286](/filings/0001803914-24-000071.md) | [287](/filings/0001803914-24-000103.md) | [269](/filings/0001628280-26-018238.md) | [264](/filings/0001803914-25-000087.md) | [263](/filings/0001803914-25-000122.md) | [275](/filings/0001628280-25-051637.md) | [274](/filings/0001628280-26-055279.md) | [252](/filings/0001628280-26-033562.md) | [266](/filings/0001628280-26-055279.md) |
| Long-term debt | $m | [188](/filings/0001803914-24-000011.md) | [190](/filings/0001803914-25-000030.md) | [193](/filings/0001803914-24-000035.md) | [196](/filings/0001803914-24-000071.md) | [200](/filings/0001803914-24-000103.md) | [176](/filings/0001628280-26-018238.md) | [176](/filings/0001803914-25-000087.md) | [176](/filings/0001803914-25-000122.md) | [175](/filings/0001628280-25-051637.md) | [173](/filings/0001628280-26-055279.md) | [157](/filings/0001628280-26-033562.md) | [156](/filings/0001628280-26-055279.md) |
| Current portion of debt | $m | [0.3](/filings/0001803914-24-000011.md) | [0.3](/filings/0001803914-25-000030.md) | [0.3](/filings/0001803914-24-000035.md) | [0.3](/filings/0001803914-24-000071.md) | [0.3](/filings/0001803914-24-000103.md) | [0.4](/filings/0001628280-26-018238.md) | [0.8](/filings/0001803914-25-000087.md) | [1.1](/filings/0001803914-25-000122.md) | [1.5](/filings/0001628280-25-051637.md) | [1.5](/filings/0001628280-26-055279.md) | [0.0](/filings/0001628280-26-033562.md) | [0.0](/filings/0001628280-26-055279.md) |
| Shareholders' equity | $m | [47.8](/filings/0001803914-24-000103.md) | [45.9](/filings/0001628280-26-018238.md) | [29.5](/filings/0001803914-25-000122.md) | [15.7](/filings/0001628280-25-051637.md) | [(15.7)](/filings/0001628280-25-051637.md) | [(7.7)](/filings/0001628280-26-018238.md) | [(11.4)](/filings/0001803914-25-000122.md) | [(17.5)](/filings/0001628280-25-051637.md) | [3.8](/filings/0001628280-25-051637.md) | [18.4](/filings/0001628280-26-055279.md) | [33.5](/filings/0001628280-26-033562.md) | [22.1](/filings/0001628280-26-055279.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(14.7) d](/filings/0001803914-24-000103.md) | [(1.9) d](/filings/0001803914-25-000030.md) | [(9.8)](/filings/0001803914-25-000087.md) | [(3.0) d](/filings/0001803914-25-000122.md) | [(6.5) d](/filings/0001628280-25-051637.md) | [0.2 d](/filings/0001628280-26-018238.md) | [(7.6)](/filings/0001628280-26-033562.md) | [(3.9) d](/filings/0001628280-26-055279.md) | [10.1 d](/filings/0001628280-25-051637.md) | [1.4 d](/filings/0001628280-26-018238.md) | [(8.1)](/filings/0001628280-26-033562.md) | [(0.4) d](/filings/0001628280-26-055279.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001803914-24-000103.md) | [2.1 d](/filings/0001803914-25-000030.md) | [0.6](/filings/0001803914-25-000087.md) | [0.7 d](/filings/0001803914-25-000122.md) | [0.5 d](/filings/0001628280-25-051637.md) | [0.6 d](/filings/0001628280-26-018238.md) | [0.0](/filings/0001628280-26-033562.md) | [0.4 d](/filings/0001628280-26-055279.md) | [0.3 d](/filings/0001628280-25-051637.md) | [0.3 d](/filings/0001628280-26-018238.md) | [0.6](/filings/0001628280-26-033562.md) | [0.2 d](/filings/0001628280-26-055279.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [46.9](/filings/0001803914-24-000011.md) | [65.2](/filings/0001803914-24-000035.md) | [74.9](/filings/0001803914-24-000071.md) | [73.9](/filings/0001803914-24-000103.md) | [72.7](/filings/0001803914-25-000087.md) | [73.0](/filings/0001803914-25-000122.md) | [74.6](/filings/0001628280-25-051637.md) | [92.7](/filings/0001628280-26-033562.md) | [94.4](/filings/0001628280-26-055279.md) | [113](/filings/0001628280-25-051637.md) | [114](/filings/0001628280-26-033562.md) | [115](/filings/0001628280-26-055279.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 119,807,688 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055279.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.